Advanced therapies are moving from hospitals to community settings, improving patient access and care.

Cardinal Health's 2026 report reveals that advanced therapies—gene, cell, and tissue treatments—are increasingly administered outside inpatient hospitals, shifting toward outpatient and community-based settings. This transition aims to improve patient access, flexibility, and experience by bringing life-changing treatments closer to home. Providers emphasize the importance of partnerships between health systems and community practices to ensure safe, high-quality care. Establishing these programs requires significant planning and investment, but the growing pipeline of therapies, especially in oncology and other diseases, drives momentum for expansion through 2030.